APA
BMY.RT

American Portfolios Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

American Portfolios Advisors’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,764
Closed -$1.91K – 3352
2020
Q4 		$1.91K Buy
2,764
+711
+35% +$1.51K ﹤0.01% 2713
2020
Q3 		$4.62K Buy
2,053
+400
+24% +$1.14K ﹤0.01% 2320
2020
Q2 		$5.92K Sell
1,653
-42
-2% -$152 ﹤0.01% 2174
2020
Q1 		$6.44K Buy
1,695
+221
+15% +$728 ﹤0.01% 1994
2019
Q4 		$4.44K Buy
+1,474
New +$3.83K ﹤0.01% 2329

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

American Portfolios Advisors's BMY.RT Position: Q1 2021 in Review

American Portfolios Advisors sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 2,764 shares — an estimated $1.91K sold.

American Portfolios Advisors first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $6.44K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • American Portfolios Advisors reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • American Portfolios Advisors sold 2,764 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $1.91K.
  • American Portfolios Advisors first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • American Portfolios Advisors's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $6.44K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on American Portfolios Advisors's 13F filing for Q1 2021, filed 22 Mar 2023.